Patients Reluctant to Comply With Drug-Only Psychiatric Treatment

Share this content:
Patients Reluctant to Comply With Drug-Only Psychiatric Treatment
Patients Reluctant to Comply With Drug-Only Psychiatric Treatment

TUESDAY, March 7, 2017 (HealthDay News) -- Mental health patients are more likely to reject treatment if it involves only medication, according to a study published online March 6 in Psychotherapy.

Roger Greenberg, Ph.D., a professor of psychology at the State University of New York's Upstate Medical University in Syracuse, and colleagues analyzed 186 studies of patients who sought help for mental health conditions. Overall, the average treatment refusal rate was 8.2 percent.

Patients offered drug therapy alone were 1.76 times as likely to refuse treatment as those offered psychotherapy alone, the researchers found. Among patients who started treatment, more than one in five did not complete it. Again, patients on drug-only therapy were 1.20 times more likely to drop out of treatment early. Patients with depression were 2.16 times more likely to refuse drug therapy alone, and patients with panic disorders were 2.79 times more likely to refuse drug therapy alone.

"Patients often desire an opportunity to talk with and work through their problems with a caring individual who might be able to help them better face their emotional experiences," Greenberg said in a news release from the American Psychological Association. "Psychotropic medications may help a lot of people, and I think some do see them as a relatively easy and potentially quick fix, but I think others view their problems as more complex and worry that medications will only provide a temporary or surface level solution for the difficulties they are facing in their lives."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »